title: Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
authors.affiliation: Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Dominique C
authors.initials: DC
authors.lastname: Pichard
authors.affiliation: Department of Dermatology, Duke University Medical Center, Durham, North Carolina.
authors.forename: Adela R
authors.initials: AR
authors.lastname: Cardones
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia.
authors.forename: Emily Y
authors.initials: EY
authors.lastname: Chu
authors.affiliation: Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: William L
authors.initials: WL
authors.lastname: Dahut
authors.affiliation: Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Heidi H
authors.initials: HH
authors.lastname: Kong
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D004892:Erythema Multiforme / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008297:Male; D009536:Niacinamide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib